Identification of HO-1 as a novel biomarker for graft acute cellular rejection and prognosis prediction after liver transplantation | Zendy

Junjun Jia | Zendy; Yu Nie | Zendy; Lei Geng | Zendy; Jianhui Li | Zendy; Jimin Liu | Zendy; Yifan Peng | Zendy; Junjie Huang | Zendy; Haiyang Xie | Zendy; Lin Zhou | Zendy; Shusen Zheng | Zendy

Open Access

Identification of HO-1 as a novel biomarker for graft acute cellular rejection and prognosis prediction after liver transplantation

Author(s) -

Junjun Jia,

Yu Nie,

Lei Geng,

Jianhui Li,

Jimin Liu,

Yifan Peng,

Junjie Huang,

Haiyang Xie,

Lin Zhou,

Shusen Zheng

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.01.59

Subject(s) - medicine , biomarker , liver transplantation , transplantation , microarray , tissue microarray , gastroenterology , oncology , gene expression , biology , immunohistochemistry , gene , biochemistry

A total of 287 DEPs were identified, providing a set of targets for further research. Recipients with high preoperative HO-1 expression were associated with ACR. HO-1 may be used as a potential biomarker for predicting the development of post-transplant allograft ACR and recipient's survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research